Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

On-Demand Webinar: Essential Strategies for Gene Therapy: From Assay Development to CDx Commercialization

2021-06-24T12:57:39-04:00Cell & Gene Therapy, Events|

Innovators developing gene therapies face a multitude of challenges, from the lab to the FDA. Yet a number of successful strategies are emerging that are mitigating the risks, reducing costs and smoothing out the road to approval. Listen to a panel of gene therapy experts with unique perspectives and real-world experiences share successful approaches in gene therapy development, CDx development and commercialization.

(more…)

Meeting on the Med 2021 Conference Panel: “Innovation: Shortening the Path to Commercialization in Advanced Therapies”

2021-07-07T16:14:53-04:00Cell & Gene Therapy, Events|

Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates this panel discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.

(more…)

ASGCT 2021 Conference Panel: Considerations for the Clinical Development of Cell & Gene Therapies Part 2 – Gene Therapy

2021-06-25T11:51:02-04:00Cell & Gene Therapy, Events|

Directly following the cell therapy panel discussion in part 1, Precision experts Deb Phippard and David Parker, and Project Pharma’s Tony Khoury joined C-Suite leaders from advanced therapy companies for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 2- Gene Therapy.

(more…)

ASGCT 2021 Conference Panel: Considerations for the Clinical Development of Cell & Gene Therapies Part 1 – Cell Therapy

2021-06-25T11:47:41-04:00Cell & Gene Therapy, Events|

Check out this cell therapy panel discussion from ASGCT 2021 you won’t want to miss! Precision experts David Parker, Alex Grosvenor and Megan Liles, and Project Farma’s John Khoury join biotech executives on the front lines of development for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 1 – Cell Therapy.

(more…)

Load More Posts